Table 3—

Indicators of lipid and glucose metabolism according to HRT in nondiabetic postmenopausal women aged 40–74 years: NHANES III, 1988–1994

HRT use status in nondiabetic women
Current
Previous
Never
Sample size*Mean (95% CI)Sample size*Mean (95% CI)Sample size*Mean (95% CI)
Total cholesterol (mg/dl)293224 (218–230)491231 (227–235)1,031227 (223–231)
HDL (mg/dl)29264 (61–67)48857 (55–59)1,02755 (53–56)
Non-HDL (mg/dl)292160 (153–167)487174 (170–178)1,027172 (168–176)
Total cholesterol-to-HDL ratio2923.78 (3.55–3.99)4874.40 (4.21–4.58)1,0274.54 (4.31–4.76)
Triglycerides (mg/dl)293155 (142–167)491150 (139–160)1,028139 (132–147)
Lp(a) (mg/dl)16424 (19–29)26526 (20–31)52725 (20–29)
ApoA (mg/dl)128174 (168–181)227158 (153–162)498152 (148–156)
ApoB (mg/dl)129109 (103–115)227115 (110–120)500116 (113–118)
Fibrinogen (mg/dl)292297 (283–310)488301 (292–310)1,019320 (310–330)
C-reactive protein (mg/dl)2920.60 (0.50–0.68)4920.46 (0.37–0.54)1,0230.45 (0.40–0.51)
Fasting glucose (mg/dl)30092 (91–93)50194 (93–96)1,04796 (95–96)
Fasting insulin (μU/ml)2978.59 (7.7–9.4)49710.30 (9.0–11.6)1,04310.38 (9.7–11.0)
GHb (mg/dl)2985.3 (5.21–5.33)5015.37 (5.32–5.42)1,0455.42 (5.36–5.48)
  • *

    * Unweighted sample sizes.